Drug General Information
Drug ID
D03JZC
Former ID
DIB016132
Drug Name
PF-06263507
Drug Type
Antibody
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [524349]
Company
Pfizer
Target and Pathway
Target(s) 5T4 ONCOFETAL antigen Target Info [550498]
References
Ref 524349ClinicalTrials.gov (NCT01891669) A Study Of PF-06263507 In Patients With Advanced Solid Tumors. U.S. National Institutes of Health.
Ref 550498National Cancer Institute Drug Dictionary (drug id 751006).